Converting Enzyme Inhibitors in Hemodialysis

Vertes V. , Cangiano J.I. , Berman L.B. , and Gould A. .: Hypertension in end stage renal disease. N. Engl. J. Med. 280: 978–81, 1969.

Weidmann P. , Maxwell M.H. , Lupu A.N. , Lewin A.J. , Massry S.G. : Plasma renin activity and blood pressure in terminal renal failure. N. Engl. J. Med. 285: 757–62, 1971.

Weidmann P. , Beretta-Piccoli C. , Steffen F. , Blumberg A. , and Reubi F.C. .: Hypertension in terminal renal failure. Kidney Int. 9: 294–301, 1976.

Ferreira S.H. : A bradykinin-potentiating factor (BPF) present in the venom of bothrops jararaca. Brit. J. Pharmacol. 24: 163–9, 1965.

Bakhle Y.S. : Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature. 220: 919, 1968.

MacGregor G.A. , Markandu N.K. , Bayliss J. , Roulston J.E. , Squires M. , and Morton J.J. .: Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK 421): Evidence for role of renin system in normotensive subjects. BMJ. 283: 401–4, 1981.

Vidt D.G. , Bravo E.L. , and Fouad F.M. .: Captopril. Medical Intelligence. N. Engl. J. Med. 306: 214–8, 1982.

McKinstry D.N. , Vukovich R.A. , and Knill J.R. .: Overview of the clinical pharmacology of captopril (SQ14225) in normal subjects and hypertensive patients. [In] Gross F. , and Liedtke R.K. ., eds. Pharmacology and clinical use of angiotensin I converting enzyme inhibitors: First international symposium on captopril. Munich, May 4, p. 42–56, 1979.

Rubin B. , and Antonaccio M.J. .: Captopril: Orally active ace inhibitor. (In) Scriabine A. , ed. Pharmacology of antihypertensive drugs. Raven Press, New York, p. 21–42, 1980.

Swartz S.L. , Williams G.H. , Hollenberg N.K. , Levine L. , Dluhy R.G. , and Moore T.J. .: Captopril-induced changes in prostaglandin production. J. Clin. Invest. 65: 1257–64, 1980.

Brunner H.R. , Waeber B. , Turini G.A. , Wauters J.P. , and Gavras H. .: Clinical Use of captopril in patients with hypertension or congestive heart failure. (In) Gross F. , and Liedtke R.K. ., eds. Pharmacology and clinical use of angiotensin I converting enzyme inhibitors: First international symposium on captopril. Munich, May 4, p. 57–73, 1979.

Rommel A.J. , Pierides A.M. , Heald A. : Captopril elimination in chronic renal failure. Clin. Pharmacol. & Ther. 27: 282, 1980.

Hirakata H. , Onoyama K. , Iseki K. , Omae T. , Fujimi S. , and Kawahara : Captopril (SQ14225) clearance during hemodialysis treatment. Clin. Nephrol. 16: 321–3.

Hoorntje S.J. , Donker J. , Prins E.J.I. , and Weening J.J. .: Membranous Glomerulopathy in patients on captopril. Acta Med. Scan. 208: 325–9, 1980.

Capoten (Captopril) monograph, Squibb Institute for Medical Research, pp 51.

Gavras H. , Waeber B. , Gavras I. , Biollaz J. , Brunner H.R. , and Davies R.O. .: Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor <MK-421≫. Lancet, Vol. 2, 543–7, 1981.

Vaughan D. , Carey R.M. , Ayres C.R. , and Peach M.J. .: Hemodialysis-resistant hypertension: Control with an orally active inhibitor of angiotensin-converting enzyme. J. Clin. Endocrinol Metabolism, 48: 869–71. 1979.

Wauters J.P. , Waeber B. , Brunner H.R. , Gulgnard P. , Turini G.A. , and Gavras H. .: Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction. Clin. Nephrol. 16: 86–92, 1981.

Leslie B.R. , Case D.B. , Sullivan J.F. , and Vaughan E.D. Jr. .: Absence of blood-pressure lowering effect of captopril in anephric patients. BMJ, 280: 1067–8, 1980.

Man In't Veld A.J. , Schicht I.M. , Derkx F.H.M. , De Bruyn J.H.B. , and Schalekamp M.A.D.H. .: Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure anephric subjects. BMJ. 280: 288–90, 1980.

Iseki K. , Onoyama K. , Fujimi S. , and Omae T. .: Immediate hemodynamic response to SQ14225 (Captopril) in hypertensive and normotensive hemodialysis patients. Clin. Nephrol. 16: 137–41, 1981.

Iseki K. , Onoyama K. , Fujimi S. , Fukiyama K. , and Omae T. .: Comparison of the immediate hemodynamic effects of SQ14225 (Captopril) and (Sar¹, Ileu⁸) angiotensin 11 in patients with dialysis resistant hypertension. Clin. Nephrol. 17: 149–54, 1982.

Brenner B.M. , and Rector F.C. .: The Kidney: W.B. Saunders Company, Philadelphia, London, Toronto. 2: 781–3, 1981.

Gould A.B. , Goodman S.A. , and Green D. .: An in-vivo effect of renin on erythropoietin formation. Lab. Invest. 28: 719–22, 1973.